Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

被引：0

作者：

Maria J. G. T. Vehreschild

Petar Atanasov

Kateryna Yurko

Cristian Oancea

Georgi Popov

Valentina Smesnoi

Gheorghe Placinta

Hella Kohlhof

Daniel Vitt

Evelyn Peelen

Jelena Mihajlović

Andreas R. Muehler

机构：

[1] Goethe University Frankfurt,Department of Internal Medicine, Infectious Diseases, Medizinische Klinik II, University Hospital Frankfurt

[2] UMHATEM “N.I.Pirogov” EAD,Clinic of Internal Diseases

[3] Kharkiv National Medical University,Infectious Diseases

[4] University of Medicine and Pharmacy “Victor Babeş” Timişoara,Clinic of Infectious Disease

[5] Military Medical Academy-Sofia,undefined

[6] PMSI Clinical Hospital of Infectious Diseases “Toma Ciorba”,undefined

[7] Section 3,undefined

[8] Bulevardul Ştefan Cel Mare şi Sfânt,undefined

[9] Nr 163,undefined

[10] PMSI Clinical Hospital of Infectious Diseases “Toma Ciorba”,undefined

[11] Section 4,undefined

[12] Bulevardul Ştefan Cel Mare şi Sfânt,undefined

[13] nr 163,undefined

[14] Immunic AG,undefined

来源：

Infectious Diseases and Therapy | 2022年 / 11卷

关键词：

COVID-19; Dihydroorotate dehydrogenase inhibitor; Vidofludimus calcium;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：2159 / 2176

页数：17

共 50 条

[1] Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Vehreschild, Maria J. G. T.
Atanasov, Petar
Yurko, Kateryna
Oancea, Cristian
Popov, Georgi
Smesnoi, Valentina
Placinta, Gheorghe
Kohlhof, Hella
Vitt, Daniel
Peelen, Evelyn
Mihajlovic, Jelena
Muehler, Andreas R.
INFECTIOUS DISEASES AND THERAPY, 2022, 11 (06) : 2159 - 2176
[2] Efficacy of amantadine in patients hospitalized with COVID-19: Study protocol of a randomized, double-blind, placebo-controlled trial
Lopiano, Leonardo
Artusi, Carlo Alberto
Bozzali, Marco
Ancidoni, Antonio
Ciccone, Giovannino
De Rosa, Francesco
Vanacore, Nicola
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
[3] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Bazdyrev, Evgeny
Panova, Maria
Brachs, Maria
Smolyarchuk, Elena
Tsygankova, Daria
Gofman, Liudmila
Abdyusheva, Yana
Novikov, Fedor
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[4] Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial
Evgeny Bazdyrev
Maria Panova
Maria Brachs
Elena Smolyarchuk
Daria Tsygankova
Liudmila Gofman
Yana Abdyusheva
Fedor Novikov
Journal of Translational Medicine, 20
[5] Efficacy and Safety of Inosine Pranobex in COVID-19 Patients: A Multicenter Phase 3 Randomized Double-Blind, Placebo-Controlled Trial
Jayanthi, C. R.
Swain, Ashok K.
Ganga, Ranganath T.
Halnor, Dnyaneshwar
Avhad, Ajit
Khan, Mohd Saif
Ghosh, Ayan
Choudhary, Sumer Sanjiv
Yannawar, Anand Namdevrao
Despande, Shubhangi
Patel, Manish
Anne, Krishna Prasad
Bangar, Yogesh
ADVANCED THERAPEUTICS, 2022, 5 (12)
[6] Efficacy of naproxen in the management of patients hospitalized with COVID-19 infection: A randomized, double-blind, placebo-controlled, clinical trial
Asadi, Masoomeh
Sayar, Sara
Radmanesh, Esmat
Naghshi, Sina
Mousaviasl, Sajedeh
Jelvay, Saeed
Ebrahimzadeh, Mona
Mohammadi, Asma
Abbasi, Samaneh
Mobarak, Sara
Bitaraf, Saeid
Zardehmehri, Fatemeh
Cheldavi, Ali
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (06)
[7] The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial
Kasiri, Hossein
Ghazaiean, Mobin
Rouhani, Nima
Naderi-behdani, Fahimeh
Ghazaeian, Monireh
Ghodssi-Ghassemabadi, Robabeh
JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (02) : 124 - 131
[8] Nitazoxanide in Patients Hospitalized With COVID-19 Pneumonia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
Rocco, Patricia R. M.
Silva, Pedro L.
Cruz, Fernanda F.
Tierno, Paulo F. G. M. M.
Rabello, Eucir
Junior, Jefiton Cordeiro
Haag, Firmino
de avila, Renata E.
da Silva, Joana D. G.
Mamede, Mariana M. S.
Buchele, Konrad S.
Barbosa, Luiz C. V.
Cabral, Anna C.
Junqueira, Antonio A. F.
Araujo-Filho, Joao A.
da Costa, Lucianna A. T. J.
Alvarenga, Pedro P. M.
Moura, Alexandre S.
Carajeleascow, Ricardo
de Oliveira, Mirella C.
Silva, Roberta G. F.
Soares, Cynthia R. P.
Fernandes, Ana Paula S. M.
Fonseca, Flavio Guimaraes
Camargos, Vidyleison Neves
Reis, Julia de Souza
Franchini, Kleber G.
Luiz, Ronir R.
Morais, Sirlei
Sverdloff, Carlos
Martins, Camila Marinelli
Felix, Nathane S.
Mattos-Silva, Paula
Nogueira, Caroline M. B.
Caldeira, Dayene A. F.
Pelosi, Paolo
Lapa-e-Silva, Jose R.
FRONTIERS IN MEDICINE, 2022, 9
[9] Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
Leila N. Atmowihardjo
Job R. Schippers
Erik Duijvelaar
Imke H. Bartelink
Pierre M. Bet
Noortje E. L. Swart
Nienke van Rein
Keith Purdy
David Cavalla
Andrew McElroy
Sarah Fritchley
Anton Vonk Noordegraaf
Henrik Endeman
Patricia van Velzen
Matty Koopmans
Harm Jan Bogaard
Leo Heunks
Nicole Juffermans
Marcus J. Schultz
Pieter R. Tuinman
Lieuwe D. J. Bos
Jurjan Aman
Critical Care, 27
[10] Efficacy and safety of intravenous imatinib in COVID-19 ARDS: a randomized, double-blind, placebo-controlled clinical trial
Atmowihardjo, Leila N.
Schippers, Job R.
Duijvelaar, Erik
Bartelink, Imke H.
Bet, Pierre M.
Swart, Noortje E. L.
van Rein, Nienke
Purdy, Keith
Cavalla, David
McElroy, Andrew
Fritchley, Sarah
Vonk Noordegraaf, Anton
Endeman, Henrik
van Velzen, Patricia
Koopmans, Matty
Bogaard, Harm Jan
Heunks, Leo
Juffermans, Nicole
Schultz, Marcus J.
Tuinman, Pieter R.
Bos, Lieuwe D. J.
Aman, Jurjan
CRITICAL CARE, 2023, 27 (01)

← 1 2 3 4 5 →